These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The clinical physiology of side effects in long-term L-DOPA therapy. Barbeau A Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234 [No Abstract] [Full Text] [Related]
23. [The role of dopamine in the physiology and pathology of the basal ganglia]. Arushanian EB Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763 [No Abstract] [Full Text] [Related]
24. [Tranquilizers and neurotransmitters]. Ueki S; Yamamoto T Nihon Rinsho; 1978; 36(1):95-102. PubMed ID: 24769 [No Abstract] [Full Text] [Related]
25. [Interaction of opiates and opioid peptides with cerebral mediator systems]. Bulaev VM; RaevskiÄ KS Usp Fiziol Nauk; 1982; 13(2):65-92. PubMed ID: 6124068 [No Abstract] [Full Text] [Related]
26. [Nigrostriatal system as a source of torsion extrapyramidal disorders (review)]. Arushanian EB; Dutov AA Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):930-8. PubMed ID: 6774537 [No Abstract] [Full Text] [Related]
27. Development of neurotransmitters in the neocortex. Coyle JT Neurosci Res Program Bull; 1982 Apr; 20(4):479-91. PubMed ID: 6126844 [No Abstract] [Full Text] [Related]
28. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type. Davies P Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427 [No Abstract] [Full Text] [Related]
29. [Huntington chorea. Review of the most recent aspects of research]. Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905 [TBL] [Abstract][Full Text] [Related]
30. Progress in understanding Huntington's chorea. Barbeau A Can J Neurol Sci; 1975 May; 2(2):81-5. PubMed ID: 124199 [TBL] [Abstract][Full Text] [Related]
31. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy]. Wunderlich H; Wunderlich HP Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615 [No Abstract] [Full Text] [Related]
32. Chemistry of mood and emotion. McGeer PL; McGeer EG Annu Rev Psychol; 1980; 31():273-307. PubMed ID: 6102450 [No Abstract] [Full Text] [Related]
33. [Demonstration of the liberation of dopamine (DA) and serotonin (5HT) at the caudate nucleus level in the rat]. Besson MJ; Cheramy A; Feltz P; Glowinski J J Physiol (Paris); 1969; 61 Suppl 1():90. PubMed ID: 4323407 [No Abstract] [Full Text] [Related]
35. [Parkinson's disease: neuro-anatomical, biochemical and pharmicotherapeutic aspects]. Korf J; van Praagen HM; Lakke JP Ned Tijdschr Geneeskd; 1975 Sep; 119(36):1373-8. PubMed ID: 241026 [No Abstract] [Full Text] [Related]
36. [Metals in the metabolism of cerebral neurotransmitters. Physiological importance and metal-enzyme topographic relationships]. De Falco FA; Campanella G Acta Neurol (Napoli); 1975; 30(2):121-68. PubMed ID: 240251 [No Abstract] [Full Text] [Related]
37. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor. Fahn S; Libsch LR; Cutler RW J Neurol Sci; 1971 Dec; 14(4):427-55. PubMed ID: 5125758 [No Abstract] [Full Text] [Related]
38. Neurotransmitters in the human and nonhuman primate basal ganglia. Haber SN Hum Neurobiol; 1986; 5(3):159-68. PubMed ID: 2876974 [TBL] [Abstract][Full Text] [Related]
39. Biochemical mechanisms and management of choreiform movement disorders. de Silva L Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049 [No Abstract] [Full Text] [Related]
40. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]